Pancreatobiliary reflux and the length of a common channel

J Hepatobiliary Pancreat Sci. 2010 Nov;17(6):865-70. doi: 10.1007/s00534-010-0282-4.

Abstract

Background/purpose: Gallbladder cancer occurs frequently in patients with pancreaticobiliary maljunction due to pancreatobiliary reflux. Pancreatobiliary reflux is also detected in some patients with a relatively long common channel. This study aimed to clarify the correlation between pancreatobiliary reflux and the length of a common channel.

Methods: Two hundred and three patients, in whom both the length of a common channel and amylase level in the bile were measured, were enrolled from nine centers.

Results: Bile amylase level was correlated with the length of a common channel (P < 0.01). The minimum length of a common channel that could induce a markedly elevated amylase level in the bile (>1,000 mg/dl) was determined as 5 mm. We redefined high confluence of pancreatobiliary ducts (HCPBD) as cases with a common channel > or = 5 mm, in which the communication between the pancreatic and bile ducts was occluded with the sphincter contraction. Gallbladder cancer was found in 20% of 56 redefined HCPBD patients. Bile amylase level >1,000 mg/dl and biliopancreatic reflux were detected in 79 and 95% of the patients, respectively.

Conclusions: Patients with a common channel > or = 5 mm (redefined HCPBD) should be monitored for the development of gallbladder cancer, as they frequently showed significant pancreatobiliary reflux.

Publication types

  • Comparative Study
  • Multicenter Study

MeSH terms

  • Amylases / analysis
  • Bile / enzymology
  • Bile Reflux / complications
  • Bile Reflux / diagnosis*
  • Bile Reflux / metabolism
  • Cholangiopancreatography, Endoscopic Retrograde
  • Common Bile Duct / abnormalities*
  • Diagnosis, Differential
  • Female
  • Gallbladder Neoplasms / epidemiology
  • Gallbladder Neoplasms / etiology
  • Humans
  • Incidence
  • Japan / epidemiology
  • Male
  • Middle Aged
  • Pancreatic Diseases / complications
  • Pancreatic Diseases / diagnosis*
  • Pancreatic Diseases / metabolism
  • Pancreatic Ducts / abnormalities*
  • ROC Curve
  • Risk Factors

Substances

  • Amylases